Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation

Obstetrics and Gynecology

Volumn 108, Issue 3 II, 2006, Pages 757-761

  Pepas, Litha P ^a   Arif Adib, Merhnoosh ^a   Kadir, Rezan A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLOOD CLOTTING; CASE REPORT; CESAREAN SECTION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FETUS DISTRESS; GESTATION PERIOD; HEMOFILTRATION; HEMOSTASIS; HUMAN; HYPERTENSION ENCEPHALOPATHY; HYSTERECTOMY; KIDNEY FUNCTION; LAPAROTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PRIMIGRAVIDA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; ULTRASOUND; UTERINE ARTERY EMBOLIZATION;

CESAREAN SECTION; DISSEMINATED INTRAVASCULAR COAGULATION; EMERGENCY TREATMENT; FACTOR VIIA; FEMALE; FETAL DISTRESS; GESTATIONAL AGE; HELLP SYNDROME; HEMOSTASIS; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; INTENSIVE CARE; POSTPARTUM HEMORRHAGE; PRE-ECLAMPSIA; PREGNANCY; RECOMBINANT PROTEINS;

EID: 33748118107     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000197064.44340.d4     Document Type: Review

References (12)

1. Hedner U. NovoSeven as a universal haemostatic agent. Blood Coagul Fibrinolysis 2000;11 suppl 1:S107-11.
2. Martinowitz U, Holcomb JB, Pusateri AE, Stein M, Onaca N, Freidman M, et al. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 2001;50:721-9.
3. Roberts HR, Monroe DM, White GC. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 2004;104:3858-64.
4. O'Connell NM, Perry DJ, Hodgson AJ, O'Shaughnessy DF, Laffan MA, Smith OP. Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 2003;43:1711-6.
5. Barletta JF, Ahrens CL, Tyburski JG, Wilson RF. A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients. J Trauma. 58:646-51, 2005 Mar.
6. Moscarado F, Perez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001;114:174-6.
7. Zupanic Salek S, Sokolic V, Viskovic T, Sanjug J, Simic M, Kastelan M. Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome. Acta Haematol 2002;108:162-3.
8. Breborowicz GH, Sobieszcyk S, Szymankiewicz M. Efficacy of recombinant activated factor VII in prenatal medicine. Arch Perinatal Med 2002;8:21-7.
9. Bouwmeester FW, Jonkhoff AR, Verheijen RHM, van Geijn HP. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 2003;101:1174-6.
10. Segal S, Shemesh IY, Blumental R, Yoffe B, Laufer N, Mankuta D, et al. The use of recombinant factor VIIa in severe postpartum hemorrhage. Acta Obstet Gynecol Scand 2004;83:771-2.
11. Brice A, Hilbert U, Roger-Christoph S, Fernandez H, Dumenil AS, Descorps-Declère A, et al. Recombinant activated factor VII as a life-saving therapy for severe postpartum haemorrhage unresponsive to conservative traditional management. Ann Fr Anesth Reanim 2004;23:1084-8.
12. Boehlen F, Morales MA, Fontana P, Ricou B, Irion O, de Moerloose P. Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature. BJOG 2004;111:284-7.